Clinical Trial Update: Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of docetaxel, prednisone, and vatalanib in advanced prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• PREDNISONE (Prednisone)
• Vatalanib (vatalanib)

Snippet

Sponsor: University of California, San Francisco | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: TERMINATED